![Robert Copeland](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Copeland
Gründer bei Accent Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Robert Copeland
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.
81
| Private Company | Investment Managers | 81 |
Seton Hall University
40
| College/University | Other Consumer Services | 40 |
Subsidiary | Biotechnology | 33 | |
Corixa Corp.
![]() Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.
25
| Subsidiary | Biotechnology | 25 |
Public Company | Biotechnology | 14 | |
Accent Therapeutics, Inc.
![]() Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA.
9
| Holding Company | Biotechnology | 9 |
Rectify Pharmaceuticals LLC
![]() Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Tri-Institutional Therapeutics Discovery Institute, Inc.
![]() Tri-Institutional Therapeutics Discovery Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Memorial Sloan Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute, Inc. is an American New York-based company that encourages the Tri-Institutional community to advance their biological discoveries to preclinical studies. The company provides technical support for academic projects and offers a menu of services to translate research discoveries from bench to bedside. Tri-Institutional Therapeutics Discovery Institute achieves its mission by leveraging the infrastructure, staff, and intellectual capital of its academic and industry partners, as well as the generous support of philanthropists. The company was founded by David A. Scheinberg.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Raze Therapeutics, Inc.
![]() Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA.
2
| Extinct | Biotechnology | 2 |
Soilos, Inc.
![]() Soilos, Inc. Regional BanksFinance Soilos, Inc. is a digital asset platform that provides a comprehensive crypto-as-a-service offering to leading banks, fintech institutions, and investment applications. The company is based in Valletta, MT, and has subsidiaries in the United States. The Maltese company simplifies the complex landscape of digital assets for its institutional clients with seamless price discovery and trade execution strategies at zero slippage and no hidden fees. Soilos is the largest, most reliable prime brokerage for the world's leading institutions and the first CFTC registered swap dealer. The company was founded by Raghuveer Yarlagadda and Prabhakar Reddy, and the CEO is Raghu Yarlagadda.
1
| Holding Company | Regional Banks | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Robert Copeland
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Atlas Venture Life Science Advisors LLC
![]() Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Director of Finance/CFO Consultant / Advisor Consultant / Advisor Private Equity Investor Consultant / Advisor | |
Nimbus Therapeutics LLC
![]() Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member Corporate Officer/Principal Consultant / Advisor Chief Operating Officer Chief Executive Officer Private Equity Investor | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Private Equity Investor | |
HotSpot Therapeutics, Inc.
![]() HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Chairman Consultant / Advisor Founder Director/Board Member Founder Corporate Officer/Principal | |
KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Director/Board Member Director/Board Member Founder Private Equity Investor | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Q32 Bio, Inc.
![]() Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Founder Chairman Founder Chief Executive Officer Founder Consultant / Advisor | |
Disarm Therapeutics, Inc.
![]() Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Consultant / Advisor Founder Private Equity Investor Chief Tech/Sci/R&D Officer Private Equity Investor | |
Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
THIRD HARMONIC BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member Investor Relations Contact Director/Board Member | |
SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Chief Operating Officer Chief Operating Officer | |
Annovation BioPharma, Inc.
![]() Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Corporate Officer/Principal | |
Arteaus Therapeutics LLC
![]() Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer Founder Corporate Officer/Principal | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Navitor Pharmaceuticals, Inc.
![]() Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Navitor Pharmaceuticals, Inc. develops medicine for age-related diseases. Its drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. The company was founded by Alan L. Crane, David Sabatini and David Goldfarb and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer | |
SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Chief Operating Officer | |
XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Korro Bio, Inc.
![]() Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member Private Equity Investor Chief Executive Officer | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
Padlock Therapeutics, Inc.
![]() Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Rodin Therapeutics, Inc.
![]() Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
GENERATION BIO CO. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Director of Finance/CFO Investor Relations Contact | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
SHIRE | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Nimbus Apollo, Inc.
![]() Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
eGenesis, Inc.
![]() eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chairman Chief Executive Officer Corporate Officer/Principal | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
TRANSLATE BIO, INC. | Biotechnology | Founder Director/Board Member Director/Board Member | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
Longwood Fund Management LLC
![]() Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Private Equity Investor | |
Matchpoint Therapeutics, Inc.
![]() Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Matchpoint Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company aims to discover and develop precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. Matchpoint's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. The company was founded by Jianwei Che, Edward Chouchani, Tinghu Zhang, Nathanael S. Gray, and the CEO is G. Andre Turenne. | Biotechnology | Chairman Chief Executive Officer Chief Invt Officer-Spezialfond | |
Cadent Therapeutics, Inc.
![]() Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Founder Chief Executive Officer | |
IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Merck Research Laboratories Massachusetts LLC
![]() Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director/Board Member |
Statistik
International
Vereinigte Staaten | 46 |
Vereinigtes Königreich | 2 |
Bermuda | 2 |
Japan | 2 |
Irland | 2 |
Sektoral
Health Technology | 37 |
Consumer Services | 9 |
Commercial Services | 4 |
Finance | 3 |
Operativ
Director/Board Member | 650 |
Corporate Officer/Principal | 252 |
Independent Dir/Board Member | 172 |
Chairman | 128 |
Chief Executive Officer | 110 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Steven Gillis | 58 |
Jean-Francois Formela | 48 |
David Mott | 45 |
Bruce Booth | 40 |
Ryan Moore | 38 |
Peter Barrett | 38 |
John Maraganore | 38 |
Christopher Lynch | 38 |
Otello Stampacchia | 37 |
Kevin Bitterman | 36 |
Carl Goldfischer | 31 |
Larry Lasky | 27 |
Mark Iwicki | 26 |
David Steinberg | 24 |
Jason Rhodes | 24 |
- Börse
- Insiders
- Robert Copeland
- Unternehmensverbindungen